Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02063698 · ClinicalTrials.gov registry record · Phase 2

Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome

A Phase 2 study of Pain, sponsored by Mayo Clinic.

Completed
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT02063698: Completed Phase 2 study of Pain, sponsored by Mayo Clinic.

NCT02063698 is a Phase 2 study of Pain that has completed, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02063698, a Phase 2 study of Pain, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This randomized pilot clinical trial studies whether auranofin will relieve pain following paclitaxel in patients who have previously experienced paclitaxel-induced pain. Auranofin is a drug given by mouth to treat other diseases such as rheumatoid arthritis, and is being studied to see if it will decrease pain following paclitaxel.

Conditions Studied

Pain

Interventions

  • OTHER placebo
  • OTHER questionnaire administration
  • DRUG auranofin

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2014-02-19
Est. Completion 2016-11-11
Phase Phase 2

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02063698

The ClinicalTrials.gov registry entry for NCT02063698 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (90% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 3 interventions - of which placebo is the first listed.

NCT02063698 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02063698 about?

NCT02063698 is a clinical study titled "Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome". This randomized pilot clinical trial studies whether auranofin will relieve pain following paclitaxel in patients who have previously experienced paclitaxel-induced pain. Auranofin is a drug given by mouth to treat other diseases such as rheumatoid arthritis, and is being studied to see if it will d...

What is the current status of trial NCT02063698?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2014-02-19. Estimated completion is 2016-11-11.

What conditions does trial NCT02063698 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT02063698?

The interventions under investigation include: placebo (OTHER), questionnaire administration (OTHER), auranofin (DRUG).

Who is sponsoring clinical trial NCT02063698?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02063698 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.